Explo vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Explo

EmergingData & Analytics

Embedded Analytics

Embedded analytics platform that lets SaaS companies add white-labeled, customer-facing dashboards and reports to their products without building a BI layer from scratch.

About

Explo is an embedded analytics platform founded in 2021 and backed by Y Combinator, purpose-built for SaaS companies that need to deliver data insights to their end customers within their own product. Rather than building a custom analytics layer from scratch — a multi-month engineering project — product teams integrate Explo's SDK and API to embed interactive dashboards, charts, and reports directly inside their applications. The result is a white-labeled analytics experience where end users never leave the host product, and the SaaS company maintains brand consistency and control over the data exposure.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.